Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:OKLO
NYSE:OKLOElectric Utilities

Oklo Grant Highlights Nuclear Fuel Recycling Ambitions And Business Model Shift

Oklo (NYSE:OKLO) has been awarded a U.S. Department of Energy grant to study radioactive materials in hot liquid salt. The project supports development of what is planned to be the first U.S. nuclear fuel recycling facility in Tennessee. The facility is intended to recycle used nuclear fuel into fuel for advanced reactors, with potential implications for nuclear sustainability in the U.S. For you as an investor, this grant places fresh attention on Oklo's role in advanced nuclear technology...
LSE:ULVR
LSE:ULVRPersonal Products

Is Unilever (LSE:ULVR) Fairly Priced After Portfolio Reshaping And Cost Efficiency Push?

If you are wondering whether Unilever’s current share price reflects its true worth, you are not alone. Many investors are asking if the stock still offers value at today’s levels. Over recent periods, Unilever’s share price closed at £51.65, with returns of 3.5% over 7 days, 8.9% over 30 days, 7.1% year to date, 6.2% over 1 year, 25.7% over 3 years and 44.9% over 5 years. This naturally raises questions about what is already priced in. Recent news around Unilever has focused on its position...
NYSE:KO
NYSE:KOBeverage

Coca-Cola Reconsiders Growth As Pricing Power Meets Volume Headwinds

Coca-Cola (NYSE:KO) is facing fresh pressure on its long-used pricing power as volume growth slows and turns negative in several key markets. The company is leaning more on premium, health-oriented products, including brands such as Fairlife milk, to respond to changing consumer preferences. Coca-Cola's CEO has flagged a resumption of bolt-on mergers and acquisitions as part of a wider plan to adjust the group’s growth approach. Coca-Cola, the global beverages group behind its namesake soda...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Summit Therapeutics (SMMT) Is Up 6.5% After FDA Accepts Ivonescimab BLA With 2026 PDUFA Date

Summit Therapeutics Inc. previously announced that the FDA accepted for filing its Biologics License Application for ivonescimab plus chemotherapy in EGFR‑mutated, locally advanced or metastatic non-squamous NSCLC after tyrosine kinase inhibitor therapy, assigning a PDUFA action date of November 14, 2026. Beyond this U.S. filing, Summit and partner Akeso have broadened ivonescimab’s late-stage program across multiple Phase III trials and tumor types, underscoring a concerted push to position...
NYSE:XPEV
NYSE:XPEVAuto

XPeng Hong Kong Charging Deal With Antom Highlights Global Services Ambition

XPeng has launched smart charging payment services in Hong Kong through a global partnership with Antom. The rollout introduces a unified system that supports multiple local payment methods for EV charging. The service is designed to simplify cross border charging payments for XPeng drivers and other EV users. XPeng (NYSE:XPEV), trading at around $17.54, is adding this smart charging payment launch to a period of mixed share performance, with the stock up 6.4% over the past week but lower...
SEHK:1211
SEHK:1211Auto

BYD Lawsuit Challenges Trump Tariffs And Reshapes Trade Risk For Investors

BYD has filed a lawsuit against the U.S. government challenging Trump-era tariffs on its products. The company is seeking to void the tariffs and recover duties already paid. This is the first legal action of its kind by a Chinese automaker against these U.S. trade measures. BYD, listed as SEHK:1211, is bringing this legal move at a time when its shares last closed at HK$93.55. Over the past 3 years the stock return is 20.1%, compared with a 9.4% return over 5 years, while the 1 year return...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Assessing Zoetis (ZTS) Valuation As Earnings Expectations Build Ahead Of February 12 Results

Dividend affirmation and earnings catalyst Zoetis (ZTS) has reaffirmed its shareholder return plans with a second quarter 2026 dividend of $0.53 per share, while investors watch the upcoming February 12 earnings and guidance for signals on future performance. See our latest analysis for Zoetis. Zoetis shares trade at $127.30, with a 90 day share price return of 5.98% contrasting with a 1 year total shareholder return decline of 24.87%. This suggests recent momentum has not yet translated into...
NYSE:MTD
NYSE:MTDLife Sciences

Mettler Toledo Q4 Service Milestone Highlights Growth And Valuation Tension

Mettler-Toledo International (NYSE:MTD) reported strong Q4 results, with broad-based growth across regions and product lines. The company reached US$1b in annual service revenue for the first time, marking a key milestone in its service business. Management highlighted continued progress in automation and digitalization initiatives, alongside expansion in emerging markets and high-growth segments. Results came despite ongoing headwinds from tariffs and currency movements. Mettler-Toledo...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) Is Up 5.8% After TSMC Tool Progress And Semilab Deal - Has The Bull Case Changed?

Onto Innovation recently advanced toward shipping and qualifying its flagship Dragonfly 5 system for TSMC and announced plans to acquire Semilab, a move expected to enhance its materials characterization and wafer contamination monitoring capabilities. This combination of a high‑end tool qualification with a leading foundry and an accretive acquisition could materially reshape Onto Innovation’s competitive position and profitability profile within semiconductor process control. We’ll now...
TSX:SAP
TSX:SAPFood

Profit Rebound and Efficiency Push Might Change The Case For Investing In Saputo (TSX:SAP)

Saputo Inc. recently reported third-quarter fiscal 2025 results showing sales of C$4,888 million, a return to net income of C$220 million from a sizeable loss a year earlier, while also affirming a C$0.20 per-share dividend payable in March 2026. The company coupled this profitability rebound with ongoing capital investment and manufacturing consolidation, including a C$180 million Ripon facility upgrade and completed share repurchases totaling 19,882,237 shares for C$586.36 million under a...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

The Bull Case For Nova (NVMI) Could Change Following Major Nova Metrion Adoption In Leading Fabs – Learn Why

In January 2026, Nova Ltd. announced that global leaders in Memory and Logic device production adopted its Nova Metrion platform for Gate-All-Around and advanced DRAM manufacturing, using its fully automated inline Secondary Ion Mass Spectrometry system to improve performance and yield. This adoption expands Nova’s materials metrology presence directly inside advanced fabs, moving high‑precision chemical depth profiling from offline labs into real‑time production control. We’ll now examine...
BME:GRF
BME:GRFBiotechs

Is Grifols (BME:GRF) Share Price Reflecting Recent Balance Sheet Concerns?

If you are wondering whether Grifols at €11.06 is offering fair value or a potential discount, you are in the right place for a clear, valuation focused look at the stock. The share price return sits at 1% over the last week, with a 2.9% decline over the past month and a 32% gain over the last year, which can change how investors think about both upside potential and risk. Recent headlines around Grifols have kept the company on many investors' radar, including ongoing discussion of its...
SEHK:1299
SEHK:1299Insurance

AIA Group Links Health Research And New Directors To Growth Focus

AIA Group released new research on how traditional health stereotypes affect wellbeing across Asia and rolled out the next phase of its Rethink Healthy campaign. The company also announced new independent non executive directors, including an industry veteran and a fintech specialist, to its board. These moves come as AIA Group, ticker SEHK:1299, continues to refine its positioning in the regional health and insurance space. AIA Group, trading at HK$86.35, sits in a sector where brand trust...
TSX:BCE
TSX:BCETelecom

Assessing BCE (TSX:BCE) Valuation After 2025 Results And Cautious 2026 Guidance

Why BCE (TSX:BCE) is back in focus after its latest results BCE (TSX:BCE) is drawing fresh attention after reporting its fourth quarter and full year 2025 results, issuing 2026 guidance, and affirming its quarterly dividend on the same day. The company reported Q4 2025 revenue of CA$6,404 million compared with CA$6,422 million a year earlier, with net income of CA$630 million compared with CA$504 million and basic EPS from continuing operations of CA$0.64 compared with CA$0.51. For 2025 as a...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen Refocuses On High-Need Neurology As New Drugs Reach Inflection Point

Biogen (NasdaqGS:BIIB) reports strong commercial performance for Alzheimer’s treatment Leqembi, reflected in collaboration revenues and in market sales. The US FDA grants Breakthrough Therapy Designation to litifilimab for cutaneous lupus erythematosus, marking a key step in Biogen’s immunology efforts. Biogen announces promising clinical results for a high dose SPINRAZA regimen for spinal muscular atrophy, with regulatory review ongoing in the US and approvals already in the EU and...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

A Look At BWX Technologies (BWXT) Valuation As Earnings And Digital Modernization Draw Focus

Why BWX Technologies stock is back in focus BWX Technologies (BWXT) is in the spotlight as investors weigh upcoming fourth quarter earnings expectations alongside fresh digital initiatives, including a new Florida Digital Center and a leadership change in the chief digital officer role. See our latest analysis for BWX Technologies. BWX Technologies’ recent digital expansion in Florida and the appointment of a new chief digital officer come as the shares trade at $203.0, with an 11.63%...
NYSE:GME
NYSE:GMESpecialty Retail

Reassessing GameStop (GME) Valuation After Recent Volatility And Bold $220 Fair Value Narrative

Why GameStop Is Back in Focus for Investors GameStop (GME) is back on many watchlists after recent trading left the stock with a mix of short term losses and gains, prompting investors to reassess what is currently priced in. See our latest analysis for GameStop. Recent trading has been choppy, with a 1-day share price return of 1.36% decline and a 7-day share price return of 4.68% decline. However, the 30-day and year to date share price returns of 16.06% and 19.50% suggest momentum has been...
SGX:D05
SGX:D05Banks

Assessing DBS Group Holdings (SGX:D05) After Strong 1‑Year Rally And Regulatory Focus

If you are wondering whether DBS Group Holdings is offering fair value at today’s price, you are not alone. This article will walk through what the current market price might be implying. With the share price at S$58.19 and returns of 3.2% year to date and 36.0% over the past year, DBS has been on many investors’ watchlists. This is despite a 1.2% decline over the last 7 days and a more modest 1.0% return over the past month. Recent news around DBS has largely focused on its position as a...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Radware’s New Agentic AI Protection Platform Might Change The Case For Investing In Radware (RDWR)

In early February 2026, Radware launched its Agentic AI Protection Solution, expanding its platform into AI security with real-time behavioral defenses against agent-specific risks such as prompt injection, tool abuse, human–agent trust exploitation, and unauthorized data access. By aligning with the OWASP Top 10 for Agentic AI and integrating a dynamic Risk Graph Map, Radware is positioning this solution as a comprehensive framework for assessing and managing complex multi-agent AI...
NYSE:ULS
NYSE:ULSProfessional Services

Assessing UL Solutions (ULS) Valuation After Recent Share Price Weakness And Mixed Returns

What UL Solutions’ Recent Returns Tell You Right Now UL Solutions (ULS) has seen mixed share performance recently, with a 1 day return of 0.99% and a modest gain over the past week, set against weaker moves over the month and past 3 months. For longer term context, the stock’s year to date performance reflects a 10.77% decline, while the 1 year total return stands at 33.10%. These figures provide a snapshot of how recent trading compares with a fuller 12 month picture. See our latest analysis...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Opera (OPRA) Is Down 7.9% After Boosting 2025 Revenue Outlook on MiniPay Stablecoin Expansion - Has The Bull Case Changed?

In February 2026, Tether announced the expansion of USDT and Tether Gold support within Opera’s MiniPay wallet on the Celo blockchain, highlighting millions of users across emerging markets and hundreds of millions of transactions, while Opera also guided full-year 2025 revenue to exceed US$608,000,000, over US$130,000,000 higher than 2024. The combination of MiniPay’s large, fast-growing self-custodial stablecoin user base and raised revenue expectations underscores Opera’s shift toward...
TASE:ORL
TASE:ORLOil and Gas

Middle Eastern Penny Stocks To Watch In February 2026

As tensions ease following positive US-Iran talks, most Gulf stocks have risen, supported by upbeat corporate earnings. This optimistic market environment highlights the potential for smaller or newer companies to gain traction and deliver value. Although 'penny stock' is an older term, it still signifies opportunities in these emerging firms when they are backed by strong financials and growth potential.